Jeffrey M. Jonas, President & CEO at Sage Therapeutics, Inc. (SAGE), sold 49,208 shares at $175.09 ($8.6M) on 2019-05-23, disclosed to the SEC on 2019-05-24.
Open-market sale of $8.6M SAGE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $172.20 | 1,619 | $279K | 3.2% |
| 2 | $174.46 | 31,099 | $5.4M | 63.1% |
| 3 | $175.09 | 14,727 | $2.6M | 30.0% |
| 4 | $176.15 | 1,763 | $311K | 3.6% |
| Total | $174.63 avg | 49,208 | $8.6M | 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |